Thyrocare Technologies Limited (NSE:THYROCARE)
India · Delayed Price · Currency is INR 1,265.30
-12.90 (-1.01%)
Aug 29, 2025, 3:30 PM IST
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 67.03 billion as of August 29, 2025. Its market cap has increased by 51.56% in one year.
Market Cap
67.03B
Enterprise Value
65.73B
Revenue
7.23B
Ranking
n/a
PE Ratio
63.08
Stock Price
1,265.30
Market Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 67.03B, an increase of 101.89%. That is a compound annual growth rate of 7.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 67.03B | 38.32% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | 48.30B | 67.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,825.74B |
| Divi's Laboratories | 1,627.72B |
| Cipla | 1,283.84B |
| Apollo Hospitals Enterprise | 1,094.20B |
| Mankind Pharma | 1,020.09B |
| Zydus Lifesciences | 987.17B |
| Fortis Healthcare | 688.14B |
| Alkem Laboratories | 634.11B |